EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Synergistic Effects of DNA ‐ PKcs Inhibition and Radiotherapy in Esophageal Squamous Cell Carcinoma

Jiekun Qian, Guoliang Liao, Jianting Du, Maojie Pan, Maohui Chen, Long Wu, Xin Yan, Chun Chen iD, Bin Zheng, Zhang Yang iD

The FASEB Journal · 2026

DOI: 10.1096/fj.202503284rr ↗

Kurz gefasst

Fachartikel in der Zeitschrift The FASEB Journal, 2026. Verfasst von Jiekun Qian und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Thoracic Surgery, Fujian Medical University Union Hospital, Fuzhou, China. Hauptthemen laut MEDLINE: DNA-Activated Protein Kinase, Esophageal Neoplasms, Esophageal Squamous Cell Carcinoma, Nuclear Proteins. Die Arbeit nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundation of China, Fujian Provincial Health Technology Project, Fujian Provincial Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Esophageal squamous cell carcinoma (ESCC) is characterized by intrinsic radioresistance, primarily mediated by hyperactivation of DNA damage response (DDR) pathways. This repair capacity significantly diminishes radiotherapy efficacy, contributing to poor patient outcomes. Targeting DNA‐dependent protein kinase catalytic subunit (DNA‐PKcs), a master regulator of non‐homologous end joining (NHEJ), represents a promising strategy to overcome radioresistance. Immunohistochemistry (IHC) was performed on paired biopsy specimens from esophageal squamous cell carcinoma (ESCC) patients ( n = 20) collected before neoadjuvant radiotherapy and after surgical resection. In vitro, ESCC cell lines (TE13 and Eca9706) were co‐treated with DNA‐dependent protein kinase catalytic subunit (DNA‐PKcs) inhibitors (AZD7648 or NU7741) or PRKDC‐targeting siRNA plus irradiation. Subsequent functional assays were conducted to assess cell viability, apoptosis, cell cycle distribution, and underlying molecular mechanisms. In vivo, the combined efficacy of AZD7648 and irradiation was evaluated in xenograft tumor models. Phosphorylated DNA‐PKcs (Ser2056) in ESCC tissues was significantly elevated following irradiation. Inhibition of DNA‐PKcs markedly enhanced radiosensitivity in both ESCC cell lines and xenograft models, correlating with prolonged G2/M arrest and increased apoptosis. Mechanistically, the combined therapy activated the ATM (Ser1981)‐Chk2 (Thr68) axis and concurrently enhanced phosphorylation of Chk1 at Ser345, reinforcing G2/M arrest through Wee1 kinase‐mediated inhibitory phosphorylation of CDC2 at Tyr15. Consequently, irreparable DNA double‐strand breaks (DSBs) accumulated, triggering Caspase‐3‐dependent cleavage of PARP and execution of the intrinsic apoptosis pathway. Our study reveals a novel mechanism by which DNA‐PKcs inhibition augments radiosensitivity in ESCC. Targeting DNA‐PKcs could represent a promising strategy to improve the efficacy of radiotherapy in ESCC, offering a potential therapeutic approach to overcome radioresistance.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DNA-Activated Protein KinaseEsophageal NeoplasmsEsophageal Squamous Cell CarcinomaNuclear ProteinsProtein Kinase InhibitorsHumansAnimalsCell Line, TumorMiceApoptosisMice, NudeMorpholinesChromonesFemaleXenograft Model Antitumor AssaysMaleRadiation ToleranceMice, Inbred BALB C

Stichwörter der Autor:innen

DNA damage response (DDR)DNA‐PKcs inhibitionesophageal squamous cell carcinoma (ESCC)radiosensitivity

Substanzen

DNA-Activated Protein KinasePRKDC protein, humanMorpholinesChromones8-dibenzothiophen-4-yl-2-morpholin-4-yl-chromen-4-oneNuclear Proteins2-(morpholin-4-yl)benzo(h)chromen-4-oneProtein Kinase Inhibitors

Autor:innen und Institutionen

  • Department of Thoracic Surgery, Fujian Medical University Union Hospital, Fuzhou, China.
  • Fujian Key Laboratory of Cardiothoracic Surgery (Fujian Medical University), Fuzhou, China.
  • Clinical Research Center for Thoracic Tumors of Fujian Province, Fuzhou, China.
  • Department of Pathology, Fujian Medical University Union Hospital, Fuzhou, China.
  • Department of Cardiac Medical Center Nursing, Fujian Medical University Union Hospital, Fuzhou, China.

ORCID-Profile: Chun Chen, Zhang Yang

Förderung

  • National Natural Science Foundation of China
  • Fujian Provincial Health Technology Project
  • Fujian Provincial Natural Science Foundation of China
  • Talent Fund Project of Fujian Medical University Union Hospital
  • Fujian Medical University

Zitieren

APA

Qian, J., Liao, G., Du, J., Pan, M., Chen, M., Wu, L., Yan, X., Chen, C., Zheng, B., & Yang, Z. (2026). Synergistic Effects of DNA ‐ PKcs Inhibition and Radiotherapy in Esophageal Squamous Cell Carcinoma. The FASEB Journal. https://doi.org/10.1096/fj.202503284rr

Vancouver

Qian J, Liao G, Du J, Pan M, Chen M, Wu L, et al. Synergistic Effects of DNA ‐ PKcs Inhibition and Radiotherapy in Esophageal Squamous Cell Carcinoma. The FASEB Journal. 2026. doi:10.1096/fj.202503284rr

BibTeX
@article{Qian2026,
  author = {Qian, Jiekun and Liao, Guoliang and Du, Jianting and Pan, Maojie and Chen, Maohui and Wu, Long and Yan, Xin and Chen, Chun and Zheng, Bin and Yang, Zhang},
  title = {Synergistic Effects of DNA ‐ PKcs Inhibition and Radiotherapy in Esophageal Squamous Cell Carcinoma},
  journal = {The FASEB Journal},
  year = {2026},
  doi = {10.1096/fj.202503284rr}
}
Kostenlos starten →